Please login to the form below
opioids
This page shows the latest opioids news and features for those working in and with pharma, biotech and healthcare.
Mallinckrodt files for bankruptcy protection in the US
The bankruptcy filing will reduce Mallinckrodt’s debt by approximately $1.3bn and resolve the opioid-related claims against the company. ... Another opioid drugmaker – Purdue Pharma – filed for bankruptcy last year following increasing blame for
Latest news
-
Alkermes’ new antipsychotic clears FDA advisory committee hurdle
The committees also jointly voted 11-6 that the labelling is sufficient to mitigate the risks related to the opioid antagonist action of samidorphan. ... Alkermes’ proposed labelling warns against the use of ALKS 3831 in patients who are
-
US states claim Purdue Pharma owes $2.2 trillion over opioid crisis
Last year, Purdue filed for bankruptcy following increasing blame for its part in driving the opioid epidemic in the US. ... well as millions of doses of lifesaving opioid addiction treatment and overdose reversal medicines,” Purdue said in a statement.
-
Q&A: Kate Paxton
opioid crisis was also incredibly rewarding.
-
Trevena gets second go at FDA approval for pain drug
The FDA has set a date of 7 August to complete its review of the marketing application for the intravenously-administered drug, a mu-opioid receptor agonist which is billed as ... the risk of respiratory and gastrointestinal side effects seen with other
-
US piles pressure on Mallinckrodt over alleged Acthar fraud
settle claims that it had a hand in fuelling the opioid epidemic in the US.
More from news
Approximately 34 fully matching, plus 149 partially matching documents found.
Latest Intelligence
-
20 for 2020 – Five pharma leaders to watch in 2020
Hahn is taking over as the FDA is being thrust into the spotlight on a number of issues, including how to deal with medicine prices, the opioid epidemic, hastening access to
-
20 for 2020 – Five pharma companies to watch
year. We’re talking about the lawsuits J&J is facing claiming damages as a result of using its products, including opioid painkillers, Baby Powder talc and its schizophrenia drug Risperdal ... epidemic in opioid abuse and overdose-related deaths in the
-
Will biosimilars ever catch on in the US?
First-to-market generics included medicines for opioid overdose, pulmonary arterial hypertension, breast cancer, seizures, depression and various infections.
-
The transatlantic opioid crisis
There’s some evidence to suggest similar transgressions in the UK with opioids. ... In another case, a single GP had ten patients addicted to synthetic opioids.
-
As the opioid crisis grabs the headlines, the search for safe treatments continues
European operations, said the company is close to new registrations in Europe for opioid addiction products. ... be fully dedicated to helping patients, doctors and communities dealing with opioid addiction.’.
More from intelligence
Approximately 2 fully matching, plus 25 partially matching documents found.
Latest appointments
-
New faces at Merus, Rubius Therapeutics and Titan Pharmaceuticals
DeVarney joined Titan over ten years ago, and has lead the development of its opioid addiction treatment Probuphine.
-
Egalet appoints Stan Musial as CFO
s pipeline of abuse-deterrent opioids are nearing phase III.
More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.
Latest from PMHub
-
Improving Outcomes in the Treatment of Opioid Dependence Highlights Report
The 16th annual ‘Improving Outcomes in the Treatment of Opioid Dependence’ (IOTOD) conference took place at the Hilton Madrid Airport hotel on 15–16 May 2018. ... The two-day event succeeded in delivering what IOTOD is well known for: expert
-
IOTOD: Improving Opioid Dependence Outcomes
IOTOD’s future. The IOTOD educational initiative perpetually aims to provide the most up-to-date information in the field of opioid addiction. ... in opioid addiction and gain valuable insight on some of the most controversial topics in the field.
-
"Legal highs" ruling leaves illegal labs laughing
So we are acutely aware of the devastation caused by the opioid epidemic in the US, and the criticism aimed at Purdue, the maker of OxyContin. . ... We have also pitched for agents designed to treat opioid overdose and alcohol abuse. .
-
Research Partnership has published a new Living with Chronic Pain market report for 2016
At least 60% of the patients surveyed are currently prescribed long acting opioids (LAOs).
-
How digital content is helping physicians curb the opioid abuse epidemic
using their state’s Prescription Drug Monitoring Program (PDMP) database before prescribing opioids to a patient. ... topic. And there’s plenty of evidence that this approach works—having a measurable and almost immediate impact on how physicians
More from PMHub
Approximately 1 fully matching, plus 5 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
- Regeneron seeks US emergency use authorisation for COVID-19 antibody cocktail
- Pfizer CEO pushes back COVID-19 vaccine submission to November
- Pfizer CEO pushes back COVID-19 vaccine submission to November
- Galapagos mid-stage trial failure raises concerns for Gilead deal
- Eli Lilly’s COVID-19 antibody trial paused due to safety issue
- Lilly buys biotech firm Disarm Therapeutics for $135m
- Neurofibromatosis: a condition that’s hard to say, but even harder to live with
- Do you know what PoTS is?
- St John & St Elizabeth Hospital “Putting people first” by Seven Stones
- OPEN Health delivers over 250 virtual activities during COVID-19 – A clear path forward
- Moderna’s chief exec expects to have COVID-19 vaccine data in November
- UK government invests in human challenge trials for COVID-19
PMHub
Wilmington Healthcare
A heritage to envy Wilmington Healthcare brings together the data intelligence specialisms of Binley’s, NHiS, Wellards and HSJ to create...
Latest intelligence
- OPEN Health delivers over 250 virtual activities during COVID-19 – A clear path forward
- ...
- Can eLearning improve patient recruitment and retention?
- Some patients will still want to read pages of informed consent forms before joining a clinical trial, or want timely updates on paper rather than a notification on their phone....
- How Far Do You Want To Go?
- Join OPEN Health's virtual careers event on Tuesday 10th November, 15:00–17:00 GMT and discover where a career in medical communications could take you…...
Quick links
Infographics
